toripalimab
junshi biosciences,coherus
['neotorch', 'toripalimab', 'nsclc', 'ts,perio,1', 'sclc', 'ts,perio,i']
1: fresh from #asco23: interim results from the neotorch study offer promising developments for stage ii/iii nsclc treatment. the study explores the efficacy and safety of perioperative toripalimab plus chemotherapy. .
🫁Pneumo-Onco🩺 Chef de Pôle de Méd à Orientation Onco 🏥 @CHToulonLaSeyne 🔬Conseil Scientifique @IFCTLung / Pdte du 3C VarOuest 👉🏼#HopitalPublic #LungCancer